Stockscreener 앱 받기
23.46
2.09%
0.48
시간 외 거래:
23.54
0.08
+0.34%
전일 마감가:
$22.98
열려 있는:
$23.21
하루 거래량:
569.66K
Relative Volume:
0.53
시가총액:
$2.01B
수익:
$1.13B
순이익/손실:
$62.75M
주가수익비율:
37.24
EPS:
0.63
순현금흐름:
$170.92M
1주 성능:
+1.91%
1개월 성능:
+12.84%
6개월 성능:
+6.54%
1년 성능:
-16.99%
1일 변동 폭
$23.19
$23.54
1주일 범위
$21.83
$23.54
52주 변동 폭
$13.39
$29.65
Progyny Inc Stock (PGNY) Company Profile
명칭
Progyny Inc
전화
212-888-3124
주소
1359 BROADWAY, NEW YORK, NY
PGNY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.46 | 1.97B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
292.51 | 258.65B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
304.34 | 80.16B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
61.85 | 77.27B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
296.60 | 63.44B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
237.12 | 27.89B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-08 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-13 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | 개시 | JMP Securities | Mkt Outperform |
| 2024-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-09-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-22 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-05 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | 개시 | Truist | Buy |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-09-30 | 개시 | Berenberg | Buy |
| 2021-08-12 | 개시 | Barclays | Overweight |
| 2021-06-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-02 | 개시 | Guggenheim | Buy |
| 2019-11-19 | 개시 | Citigroup | Buy |
| 2019-11-19 | 개시 | Goldman | Buy |
| 2019-11-19 | 개시 | JP Morgan | Overweight |
| 2019-11-19 | 개시 | Piper Jaffray | Overweight |
| 2019-11-19 | 개시 | SVB Leerink | Outperform |
모두보기
Progyny Inc 주식(PGNY)의 최신 뉴스
What drives Progyny Inc. stock priceBreakthrough financial growth - Autocar Professional
Is Progyny Inc. a good long term investmentPhenomenal trading returns - jammulinksnews.com
Progyny Inc. Stock Analysis and ForecastFree Investment Case Studies - jammulinksnews.com
When (PGNY) Moves Investors should Listen - news.stocktradersdaily.com
What analysts say about Progyny Inc. stockUnstoppable investment returns - jammulinksnews.com
Progyny Investors Wait For Growth To Catch Up To Hope - Finimize
Progyny Stock Gains 3.1% Amid Market Rally and Earnings OptimismNews and Statistics - IndexBox
Why Progyny (PGNY) Stock Is Up Today - Yahoo Finance
Why Progyny (PGNY) Stock Is Falling Today - Yahoo Finance
Truist Securities Maintains Hold Rating on Progyny (PGNY), Raise - GuruFocus
Progyny: Truist Securities Maintains Hold, Raises PT to $27 from $24. - AInvest
Progyny (PGNY) Price Target Increased Amid Mixed Investor Sentim - GuruFocus
Progyny partners with Oura for women’s health monitoring By Investing.com - Investing.com Nigeria
Where are the Opportunities in (PGNY) - news.stocktradersdaily.com
Progyny Secures $200M Credit Facility with JPMorgan - TipRanks
Progyny rises on guidance update - MSN
Progyny and Oura: A Wearable Tech Revolution in Women's Health and Its Implications for Investors - AInvest
Progyny, Inc. shares fall 1.31% after-hours following partnership announcement with ŌURA. - AInvest
Progyny (PGNY) Partners with OURA to Enhance Healthcare Monitori - GuruFocus
Progyny (PGNY) Partners with OURA to Enhance Healthcare Monitoring | PGNY Stock News - GuruFocus
Progyny partners with Oura for women’s health monitoring - Investing.com Australia
Progyny Partners with ?URA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause | PGNY Stock News - GuruFocus
Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause - The Manila Times
Progyny, Inc. Partners with ŌURA to Enhance Women's Health Insights Through Wearable Technology - Quiver Quantitative
Progyny Partners with ŌURA to Empower Women and Their Care - GlobeNewswire
Truist Financial Keeps Their Hold Rating on Progyny (PGNY) - The Globe and Mail
Progyny (PGNY) Receives a Hold from Canaccord Genuity - The Globe and Mail
Progyny's Wearable Health Alliance with ŌURA: A Pioneering Step Toward Data-Driven Women's Care - AInvest
BTIG Keeps Their Buy Rating on Progyny (PGNY) - The Globe and Mail
Progyny upgraded to Outperform at Leerink after positive pre-announcement - MSN
Progyny Inc Stock (PGNY): Strong Growth Post Q1 Results - Value The Markets
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength? - Yahoo Finance
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance By Investing.com - Investing.com South Africa
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance - Investing.com Nigeria
Leerink Partners upgrades Progyny stock rating to Outperform on improved membership activity - Investing.com Canada
Progyny (PGNY) Receives Rating Upgrade from Leerink Partners | P - GuruFocus
Sector Update: Health Care - MarketScreener
Progyny stock rises as BofA reiterates Buy rating on better-than-expected Q2 - Investing.com Canada
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook - Investing.com Canada
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook By Investing.com - Investing.com South Africa
Progyny (PGNY) Expects to Surpass Q2 2025 Projections - GuruFocus
Progyny expects Q2 results above previous forecast; shares gain - TradingView
Under the Radar: Hunting Smart in the Alleyway of Value and Growth - Benzinga
Progyny Inc (PGNY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
자본화:
|
볼륨(24시간):